A class action lawsuit has been filed against Hims & Hers Health, Inc. and certain officers over alleged violations of federal securities laws. Bronstein, Gewirtz & Grossman, LLC says the case covers people and entities that purchased or otherwise acquired Hims securities between Aug. 4, 2025, and July 29, 2026, inclusive. The complaint alleges Hims shared consumers’ health information with third-party advertising platforms and charged consumers for prescriptions almost immediately after they submitted intake forms, despite representing that they could consult a medical provider to find a treatment that was right for them. It further alleges the conduct subjected Hims to regulatory scrutiny and made the company reasonably likely to incur fees and penalties, rendering positive statements about its business, operations and prospects materially misleading or unsupported. Investors who suffered losses have until Nov. 1, 2026, to ask the court to appoint them as lead plaintiff, although participation in any recovery does not require serving in that role. The firm says it represents investors on a contingency-fee basis and seeks fees and expenses only if successful.